NTLA icon

Intellia Therapeutics

283 hedge funds and large institutions have $2.53B invested in Intellia Therapeutics in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 120 increasing their positions, 65 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

8% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 37

2% less funds holding

Funds holding: 289283 (-6)

21% less capital invested

Capital invested by funds: $3.19B → $2.53B (-$656M)

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.4M
Puts
$12.8M
Net Calls
Net Calls Change

Top Buyers

1 +$36.8M
2 +$13.4M
3 +$12.6M
4
Citadel Advisors
Citadel Advisors
Florida
+$11.6M
5
Morgan Stanley
Morgan Stanley
New York
+$7.64M

Top Sellers

1 -$8.58M
2 -$8.4M
3 -$7.86M
4
Nomura Holdings
Nomura Holdings
Japan
-$7.55M
5
Goldman Sachs
Goldman Sachs
New York
-$6.56M
Name Holding Trade Value Shares
Change
Change in
Stake
251
$5.12K
252
$5.06K
253
$4.81K
254
$4.74K
255
$4.33K
256
$3.98K
257
$3.16K
258
$2.95K
259
$2.62K
260
$2.37K
261
$2.06K
262
$1.91K
263
$1.64K
264
$1.61K
265
$1.58K
266
$1.26K
267
$1.23K
268
$917
269
$885
270
$855
271
$791
272
$728
273
$728
274
$474
275
$443